Medlive Technology Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	642.16	558.46	412	314.05	284.44
Revenue Growth (YoY)	14.99%	35.55%	31.19%	10.41%	33.21%
Cost of Revenue	256.72	231.23	160.67	101.31	83.71
Gross Profit	385.44	327.22	251.34	212.74	200.73
Selling, General & Admin	217.04	208.99	177.26	151.34	127.67
Other Operating Expenses	1.05	0.79	9.07	1.58	11.46
Operating Expenses	218.08	209.78	186.33	152.92	139.13
Operating Income	167.36	117.44	65.01	59.82	61.6
Interest Expense	-0.55	-0.79	-0.36	-0.53	-0.54
Interest & Investment Income	180.11	206.26	184.67	66.96	7.84
Earnings From Equity Investments	-	-	0.01	0.01	-0
Currency Exchange Gain (Loss)	-	3.24	-	-	-
Other Non Operating Income (Expenses)	4.58	5.19	3.81	8.78	1.02
EBT Excluding Unusual Items	351.49	331.34	253.13	135.04	69.93
Other Unusual Items	8.8	9.13	-	-	-
Pretax Income	360.29	340.47	253.13	135.04	69.93
Income Tax Expense	12.4	10.17	1.37	8.62	24.68
Earnings From Continuing Operations	347.89	330.3	251.76	126.42	45.25
Minority Interest in Earnings	-13.55	-15.16	-9.46	-9.1	-4.63
Net Income	334.34	315.15	242.3	117.32	40.62
Net Income to Common	334.34	315.15	242.3	117.32	40.62
Net Income Growth	6.09%	30.06%	106.53%	188.85%	-52.33%
Shares Outstanding (Basic)	733	729	722	714	616
Shares Outstanding (Diluted)	737	736	735	737	636
Shares Change (YoY)	0.07%	0.23%	-0.26%	15.84%	18.82%
EPS (Basic)	0.46	0.43	0.34	0.16	0.07
EPS (Diluted)	0.45	0.43	0.33	0.16	0.06
EPS Growth	6.03%	29.74%	107.09%	149.30%	-59.86%
Free Cash Flow	123.07	96.36	101.12	75.84	42.47
Free Cash Flow Per Share	0.17	0.13	0.14	0.10	0.07
Dividend Per Share	0.260	0.257	0.232	0.065	0.017
Dividend Growth	1.17%	11.06%	253.98%	284.71%	-
Gross Margin	60.02%	58.59%	61.00%	67.74%	70.57%
Operating Margin	26.06%	21.03%	15.78%	19.05%	21.66%
Profit Margin	52.06%	56.43%	58.81%	37.36%	14.28%
Free Cash Flow Margin	19.16%	17.25%	24.54%	24.15%	14.93%
EBITDA	174.99	120.66	68.92	61.72	63.73
EBITDA Margin	27.25%	21.61%	16.73%	19.65%	22.41%
D&A For EBITDA	7.63	3.22	3.91	1.9	2.13
EBIT	167.36	117.44	65.01	59.82	61.6
EBIT Margin	26.06%	21.03%	15.78%	19.05%	21.66%
Effective Tax Rate	3.44%	2.99%	0.54%	6.38%	35.30%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.